common disease among women, are influenced by estrogen [6] , it could be postulated that there may be an association between uterine fibroids and thyroid nodules. Recently, Spinos et al. released an interesting report that women with uterine fibroids had an increased incidence of thyroid nodule and estrogen might be a common pathophysiologic mechanism for the observed relationship between the two diseases [7] . Suggested findings are frequently encountered in daily clinical practice for thyroid nodule but a true meaning of simultaneous existence of uterine fibroids was not accessed till lately except this one report. This report had limitation due to a small number and no detailed description for clinical characteristics and implications, which is why we started this cross-sectional study.
Therefore, the aim of present study was to confirm cross-sectionally the relationship between thyroid nodules and uterine fibroids in women attending health check-ups based on thyroid and pelvic ultrasonographic investigation, and to identify the factors that may have an influence on the occurrence of two diseases.
Before May 2007, we had the results of total T4 level, and after that time, we used the results of free T4 level because of a change in the checking method. Total T4, free T4 and TSH levels were measured by the electrochemiluminescence immunoassay (Elecsys 1010, Roche, IN, USA). The study was approved by the institutional review board (IRB) of the Catholic university of Korea.
Statistical analysis
Correlations with a critical value of p<0.05 were considered significant. All statistics were performed using SPSS for Windows, version 12.0 (Chicago, IL, USA). Continuous variables were compared with unpaired t-test or Mann-Whitney U-test and categorical variables were analyzed based on Chi-square test. Additionally, we performed a stratified analysis based on several parameters, such as menopausal status. To find out correlation between systemic E2 level and the incidence of thyroid nodules, we analyzed the data using Spearman correlation anaylsis. We also compared the E2 levels of women having thyroid nodules with those of women not having. We had data binning into quartile by ranking the premenopausal subjects based on E2 levels, and compared the incidence of thyroid nodules between the quartiles. Multivariate logistic regression analysis was used to determine the independent factors for the occurrence of thyroid nodule.
results
Of a total of 925 patients recruited, postmenopausal women occupied 51.9% (n=480). The subjects with thyroid nodules and with uterine fibroids were 365 (39.5%) and 347 (37.5%) of 925, respectively (Table  1) . Other clinical variables likely to be associated with thyroid nodules and uterine fibroids were described in Table 1 . According to the presence of thyroid nodules, subjects with thyroid nodules were older and had higher levels of total cholesterol and triglycerides ( Table 2 ). The proportion of menopause was also significantly higher in subjects with thyroid nodules.
Compared with the premenopausal women, the post-menopausal women had less uterine fibroids 
Subjects and Methods
We retrospectively reviewed the records of 1144 participants who attended health check-ups and underwent both the thyroid and pelvic ultrasound simultaneously in Seoul St. Mary's Hospital, Seoul, Korea from January 2005 to August 2008. After exclusion of patients with total thyroidectomy or total hysterectomy, past history of thyroid disease, abnormalities in TSH level, or a medical history of lipid-lowering agents (because of a recent report of the effect of these medication on benign thyroid nodules) [8] , a total of 925 participants was included.
All participants responded to a standardized health check-up questionnaire in which the variables assessed included: age, height, weight, body mass index (BMI, m/kg 2 ), menopausal status, alcohol drinking, smoking, past medical history and present medication if any.
Total cholesterols (TC), triglycerides (TG), and HDL cholesterols were measured by enzymatic methods (AU-5421, Olympus, Tokyo, Japan). LH, FSH, and estradiol (E2) were measured by immunoradiometric assay (FSH-IRMA, LHsp-IRMA and E2-RIA-CT, DIAsource ImmunoAssays S.A., Nivelles, Belgium).
To find out correlation between systemic E2 level and the incidence of thyroid nodule, we analyzed the data of premenopausal women with normal menstruation cycle. In addition, some postmenopausal women with high estradiol level and low FSH level were excluded from a specific analysis because of the possibility of incomplete menopausal status or of potential HRT status.
During the study period, thyroid ultrasonography was performed by three experts, using HDI 5000 (Phillips Ultrasound, Bothell, WA, U.S.A.) with a 7-15 mHz transducer, according to the standard protocol of the health check-up institute. Pelvic ultrasonography was performed by one expert, using ultrasound (ALOKA Prosound SSD-α5sv, Tokyo, Japan), for the detection of uterine fibroid. The diagnosis of thyroid nodule was obtained from review of charts and radiologic reports. We defined the thyroid nodule as discrete lesion which was distinct from the surrounding thyroid parenchyma and which had solid portion regardless of having cystic portion. The size and echogenicity of dominant nodule in each subject were also presented. 
Discussion
Thyroid nodules are more common in women than in men and have been found in up to 7% of the adult population on clinical palpation [9] . Based on ultrasonographic investigations, the prevalence of thyroid nodules increases with age to more than 50% of the elderly population [10] [11] [12] . Although thyroid nodules have been recently detected with explosively increasing frequency, the association with other diseases was hardly discovered. Considering high prevalence of thyroid nodules in women, it was interesting to investigate whether accompanying obstetric disease could co-exist or not. We chose uterine fibroids as an accompanying disease because of the most common benign gynecologic disease, of which the incidence in women aged 40 to 60 is more than 30%, and affected by estrogen and progesterone [13, 14] .
Our data showed that subjects with uterine fibroids, (16.9%); P=0.002). However, the size, multiplicity of thyroid nodule, TSH, free T4 and T4 levels were not significantly different between pre-menopausal and post-menopausal women ( Table 3) . The proportion of patients with both thyroid nodule and uterine fibroid was not different on either group (77/445 (17.3%) vs. 76/480 (15.8%); P=0.548). Postmenopausal women had higher BMI, TC, TG and less HDL levels than premenopausal women (data not shown).
The relationship between thyroid nodules and uterine fibroids were found in total study subjects (P=0.010) ( Table 4) . Particularly, closer relationship between both diseases were observed within premenopausal women (n=445, 43% vs. 27.8%; P=0.001), but not in postmenopausal women (n=480, 46.9% vs. 43.4%; P=0.464) ( Table 4 ). Even after excluding menopausal women with high estrogen and low FSH (n=180), who were considered to be misclassified, the same result was shown (n=300, 42.7% vs. 42.6%; P=0.990). There was no correlation between the occurrence of uterine fibroids and multiplicity of thyroid nodules in total, premenopausal, and postmenopausal subjects (n=365 51.4% vs. 51.0%; P=0.935, n=151 50.0% vs. 49.4%; P=0.936, n=214 52.2% vs. 52.6% P=0.949, respectively). Among subjects with thyroid nodules (n=365), 117 (32.0%) had the cytology or pathology results from a fine needle aspiration or a surgery or both. Depending on these results, we evaluated the relationship between uterine fibroids and different pathologic conditions of thyroid nodules. However, we could not find any difference in the incidence of thyroid cancer between the patients with and without uterine fibroids (12/67 (17.9%) vs. 8/50 (16.0%); P= 0.786) and this fact was not dependent on the menopausal status (data not shown).
In univariate regression analysis of systemic E2 levels and the incidence of thyroid nodule in premenopausal women, systemic E2 levels had inverse correlation with the incidence of thyroid nodules (P=0.024, OR=0.631, CI: 0.424-0.940). We also found that premenopausal subjects with uterine fibroid had lower systemic estradiol levels than premenopausal subjects without uterine fibroid (P=0.038). The incidence of thyroid nodule was not different between quartiles of E2 (P=0.063) (Fig. 1) . However, if comparing the incidence of thyroid nodule between quartile 1 and quartile 4, subjects with the lowest quartile of E2 levels had a tendency to have higher incidence of thyroid nodule compared to subjects with the highest quartile particularly who were premenopausal, had higher incidence of thyroid nodule than subjects without uterine fibroids. Because thyroid nodules in our study were heterogenous, we also evaluated the relationship between uterine fibroids and some characteristics of thyroid nodules, such as multiplicity or pathologic types. The results showed there were no relationships between them. However, in multivariate logistic regression analysis, the presence of uterine fibroids was the independent factor closely associated with thyroid nodules, as also shown by the previous study [7] . No other clinical parameters but age were shown to be significantly associated with thyroid nodules. Even though the proportion of menopausal women was higher in subjects with thyroid nodules, menopausal status was not independent factor associated with thyroid nodules. It suggests that systemic E2 levels may have little effect on formation of thyroid nodules. Previously, there had been several studies focusing on effects of estrogen to explain sexual dimor-thyroid nodule in multivariate analysis, the effects of systemic E2 levels could be masked by the dominant effects of the age because increased age explained lower E2 levels, as shown in our data.
The present study, however, had several potential limitations. First, an iodine status, which was known to be a major risk factor for thyroid nodule [26] , was not assessed in each subject, although Korea was known to be iodine-sufficient area [27] , together with Japan. Second, we were not able to identify menstrual cycle when measuring the levels of FSH, LH, or E2. Third, thyroid nodules, evaluated in our study, were a heterogeneous group of the different cytology and pathology results which only reflected a part of the whole study subjects. Lastly, selection and recall bias should be considered because of the data collection from the health check-up subjects.
In conclusion, in accordance with a previous study, our results suggested uterine fibroids in women were definitely associated with thyroid nodules. However, inverse correlation of thyroid nodule incidence with E2 levels in premenopausal women should be confirmed in a well-designed study in the near future. Based on our study, we could expect that more patients with uterine fibroid also have thyroid nodule with unknown clinical significance. Another future study would be needed to clarify the clinical impact of uterine fibroids on patients with thyroid nodule to decide the probability of thyroid malignancy.
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We would like thank to Yong Kyu Park, professor of Biostatistics in College of medicine, the Catholic University of Korea, for reviewing and modifying our statistical analysis. phic prevalence of thyroid nodule. It was reported that 17β-estradiol may stimulate the growth of normal thyroid cells [15] and thyroid follicular cell contained functional estrogen receptor enhancing cell growth in vitro study, using FRTL-5 cell [16] . It was also suggested that estrogen promotes growth of both benign and malignant human thyroid cells by activating the mitogen activated protein kinase pathway [17] . Clinically, benign thyroid nodules grow slowly after menopause, which suggests thyroid nodules were dependent on sex hormones such as estrogens [18] , just as uterine fibroids tend to enlarge during pregnancy and regress after menopause [14] . Consistent with these findings, our results also suggested that both diseases were closely associated and might have common pathophysiologic mechanisms.
To find out the evidence of role of estrogen in thyroid nodule formation, we analyzed data of systemic levels of E2 in premenopausal women. However, contrary to other evidences of estrogen effect on thyroid cells in vitro as described above, our results showed the inverse relationship between the incidence of nodules and systemic E2 levels. It could be explained in two ways. First, human thyroid gland has both intracrine or paracrine estrogen responsiveness and in situ estrogen synthesis [19, 20] as uterine fibroid has [21] . In previous studies about uterine fibroids, systemic E2 levels showed no difference between subjects with uterine fibroids and without [22] [23] [24] . It is also supported indirectly by the fact that aromatase inhibitors, one of the treatment choice in managing uterine fibroids, rarely affect systemic E2 levels but reduce in situ estrogen production of uterine fibroid [25] . The same mechanism could be applied to thyroid nodule. Second, subjects with lower quartile of E2 were older than subjects with higher quartile. Regarding the age being the most significant parameter associated with references
